Clinical Trial Update: Bioequivalence Study of Tiotropium Bromide Inhalation Powder [Phase 3]

View source ↗

Summary

Phase 3 bioequivalence study of tiotropium bromide inhalation powder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Tiotropium Bromide Inhalation Powder (tiotropium bromide)

Snippet

Sponsor: Phargentis SA | Conditions: COPD | Phase 3 | Status: COMPLETED